The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 4, 2010, Pages 766-772

  Oslakovic, C ^a   Jauhiainen, M ^b   Ehnholm, C ^b   Dahlback B ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Anionic phospholipid; ApoA I; Coagulation; HDL; Phosphatidylserine; Phospholipid transfer; PLTP; Procoagulant; Prothrombinase

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOSOME; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; PROCOAGULANT; THROMBIN;

ARTICLE; BIOTRANSFORMATION; CATALYSIS; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; WESTERN BLOTTING;

ANIONS; BLOOD COAGULATION; BLOTTING, WESTERN; ENZYME ACTIVATION; HUMANS; IMMUNOPRECIPITATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOSOMES; PHOSPHOLIPID TRANSFER PROTEINS; PHOSPHOLIPIDS; THROMBIN;

EID: 77952692526     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03744.x     Document Type: Article

References (37)

1. Butenas S, Mann KG. Blood coagulation. Biochemistry (Mosc) 2002, 67:3-12.
2. Dahlback B. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases. J Intern Med 2005, 257:209-23.
3. Krishnaswamy S, Nesheim ME, Pryzdial EL, Mann KG. Assembly of prothrombinase complex. Methods Enzymol 1993, 222:260-80.
4. Griffin JH, Kojima K, Banka CL, Curtiss LK, Fernandez JA. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. J Clin Invest 1999, 103:219-27.
5. Moyer MP, Tracy RP, Tracy PB, van't Veer C, Sparks CE, Mann KG. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vasc Biol 1998, 18:458-65.
6. Kjalke M, Silveira A, Hamsten A, Hedner U, Ezban M. Plasma lipoproteins enhance tissue factor-independent factor VII activation. Arterioscler Thromb Vasc Biol 2000, 20:1835-41.
7. Saenko EL, Shima M, Sarafanov AG. Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. Trends Cardiovasc Med 1999, 9:185-92.
8. Mitropoulos KA. Lipid-thrombosis interface. Br Med Bull 1994, 50:813-32.
9. Olufadi R, Byrne CD. Effects of VLDL and remnant particles on platelets. Pathophysiol Haemost Thromb 2006, 35:281-91.
10. Curtiss LK, Valenta DT, Hime NJ, Rye KA. What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 2006, 26:12-9.
11. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008, 23:370-8.
12. Oslakovic C, Krisinger MJ, Andersson A, Jauhiainen M, Ehnholm C, Dahlback B. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins. J Biol Chem 2009, 284:5896-904.
13. Day JR, Albers JJ, Lofton-Day CE, Gilbert TL, Ching AF, Grant FJ, O'Hara PJ, Marcovina SM, Adolphson JL. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 1994, 269:9388-91.
14. Tall AR, Abreu E, Shuman J. Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J Biol Chem 1983, 258:2174-80.
15. Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 1988, 29:1593-602.
16. Huuskonen J, Wohlfahrt G, Jauhiainen M, Ehnholm C, Teleman O, Olkkonen VM. Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J Lipid Res 1999, 40:1123-30.
17. Pussinen PJ, Jauhiainen M, Metso J, Pyle LE, Marcel YL, Fidge NH, Ehnholm C. Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I. J Lipid Res 1998, 39:152-61.
18. Speijer H, Groener JE, van Ramshorst E, van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991, 90:159-68.
19. Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 2001, 155:269-81.
20. Tall AR, Krumholz S, Olivecrona T, Deckelbaum RJ. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res 1985, 26:842-51.
21. Tall AR, Forester LR, Bongiovanni GL. Facilitation of phosphatidylcholine transfer into high density lipoproteins by an apolipoprotein in the density 1.20-1.26 g/ml fraction of plasma. J Lipid Res 1983, 24:277-89.
22. Huuskonen J, Olkkonen VM, Jauhiainen M, Metso J, Somerharju P, Ehnholm C. Acyl chain and headgroup specificity of human plasma phospholipid transfer protein. Biochim Biophys Acta 1996, 1303:207-14.
23. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993, 268:4032-6.
24. Rye KA, Barter PJ. Changes in the size and density of human high-density lipoproteins promoted by a plasma-conversion factor. Biochim Biophys Acta 1986, 875:429-38.
25. Jauhiainen M, Huuskonen J, Baumann M, Metso J, Oka T, Egashira T, Hattori H, Olkkonen VM, Ehnholm C. Phospholipid transfer protein (PLTP) causes proteolytic cleavage of apolipoprotein A-I. J Lipid Res 1999, 40:654-64.
26. Rye KA, Clay MA, Barter PJ. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis 1999, 145:227-38.
27. Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Metso J, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res 2000, 41:1651-7.
28. Karkkainen M, Oka T, Olkkonen VM, Metso J, Hattori H, Jauhiainen M, Ehnholm C. Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). J Biol Chem 2002, 277:15413-8.
29. Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Biochemistry 2007, 46:11979-86.
30. Nilsson-Ehle P. nergiomsättning. Laurells Klinisk Kemi i praktisk medicin 2003, 327-59. Nilsson-Ehle P. E, In, ed, Studentlitteratur, Lund, Sweden
31. Broze GJ, Lange GW, Duffin KL, MacPhail L. Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1994, 5:551-9.
32. Siggins S, Jauhiainen M, Olkkonen VM, Tenhunen J, Ehnholm C. PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma. J Lipid Res 2003, 44:1698-704.
33. Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997, 99:315-24.
34. Lagrost L, Athias A, Gambert P, Lallemant C. Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res 1994, 35:825-35.
35. Wirtz KW. Phospholipid transfer proteins in perspective. FEBS Lett 2006, 580:5436-41.
36. Deguchi H, Pecheniuk NM, Elias DJ, Averell PM, Griffin JH. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005, 112:893-9.
37. Eichinger S, Pecheniuk NM, Hron G, Deguchi H, Schemper M, Kyrle PA, Griffin JH. High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation 2007, 115:1609-14.